• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Searches for Digital Health Products Surged 343% During UK Lockdown

Share:

October 23, 2021

Online searches for digital health products in the UK increased by 343% during the first lockdown, according to a new public health study.

Research scientists led by Simon Leigh, head of research at the Organisation for the Review of Health and Care Applications (ORCHA) examined web-based internet searches for digital health products before and during the COVID-19 pandemic.

The study, published by BMJ Open, shows that pressures put on the routine delivery of healthcare during the pandemic lead to “significant increases” in searches for digital health products.

Examining two years of collated data from January 2019 to December 2020, the team found that searches for musculoskeletal and physiotherapy products experienced the most significant increase during lockdown with a 2036% rise.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Searches for digital health products to help allergies surged by 1253%, while searches for healthy living apps increased by 1051%.

In total, 92% of medical condition areas saw an increase in searches, with the greatest soars occurring in the first two months following lockdown.

Study participants were members of the UK general population using health-app libraries provided by ORCHA.

WHY IT MATTERS

Researchers concluded that the pandemic’s disruption to routine healthcare delivery contributed to unmet clinical needs and an increased interest in the potential therapeutic medium of digital health products.

They added that future research should clarify whether this increased interest has also resulted in increased acceptance and utilization of the technologies.

THE LARGER CONTEXT

Earlier this year ORCHA published research reporting “an explosion” in digital health since COVID-19, with health app downloads up from four to five million every day.

By 2021, the organisation has partnered with organisations including the Osteopathic Health Centre in Dubai and seven Integrated Care Systems (ICSs) in South-West England to provide citizens with access to its digital health libraries.

ORCHA’s chief operating officer, Tim Andrews recently spoke to MobiHealthNews about the challenges of evaluating digital health. The organization reviews health apps against 350 measures of usability, security, and quality.

ON THE RECORD

Simon Leigh said: “We set out to explore whether demand for digital health products changed following the COVID-19 pandemic and the lockdown measures… it did! And these increases weren’t a flash in the pan at the start of lockdown – they were sustained in the nine months following the first lockdown, with 84% of condition areas still experiencing demand at least 50% greater than pre-lockdown levels.

“When we’re questioning whether GPs should revert to face-to-face appointments, perhaps we should reflect on the massive success of telehealth during COVID-19. Whilst a video or telephone call won’t work for everyone, for many patients, it works brilliantly. This could be the start of increased acceptance of a whole new generation of medical technology, and we should be encouraging GPs to use a range of approaches, including digital health products, to match the needs of patients and provide the choice they are wanting.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Value-Based Arrangements: The New Normal in BiotechValue-Based Arrangements: The New Normal in Biotech
  • Amazon’s acquisition of online pharmacy PillPack spooks retail drugstoresAmazon’s acquisition of online pharmacy PillPack spooks retail drugstores
  • Quest Diagnostics Completes Acquisition of Haystack OncologyQuest Diagnostics Completes Acquisition of Haystack Oncology
  • GuideWell to Offer Livongo for Diabetes to Florida Blue MembersGuideWell to Offer Livongo for Diabetes to Florida Blue Members
  • GE asset sale to Danaher at risk amid weak life sciences market, analyst saysGE asset sale to Danaher at risk amid weak life sciences market, analyst says
  • South Korean AI Imaging Startup AIRS Medical Scores $20M in Series B FundingSouth Korean AI Imaging Startup AIRS Medical Scores $20M in Series B Funding
  • AI’s Future In Healthcare Is Not Entirely RosyAI’s Future In Healthcare Is Not Entirely Rosy
  • Proteintech Acquires Chromotek, Expanding Its Next Generation Antibody ToolsProteintech Acquires Chromotek, Expanding Its Next Generation Antibody Tools

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications